Associated Neurosurgical Diseases

  • Miki Fujimura
  • Teiji Tominaga


Moyamoya disease is a chronic, occlusive cerebrovascular disease with unknown etiology, characterized by bilateral steno-occlusive changes at the terminal portion of the internal carotid artery and an abnormal vascular network at the base of the brain [1]. The association of moyamoya disease with further neurosurgical diseases, such as cerebral aneurysms [2, 3, 4, 5], brain tumors, cervical carotid artery stenosis, and cerebrovascular malformations, has been described previously [6–11]. It is well known that moyamoya disease is frequently associated with intracranial aneurysms located within the abnormal basal network or the circle of Willis, which are explained by the intrinsic pathology of moyamoya disease, such as hemodynamic stress and fragile structure of the collateral vessels [2, 3, 4, 5]. On the other hand, the association with atherosclerotic cervical carotid artery stenosis or with brain tumors leads to the diagnosis of akin moyamoya disease (quasi-moyamoya disease) according to the diagnostic criteria of the Research Committee on Spontaneous Occlusion of the Circle of Willis, of the Ministry of Health, Labor, and Welfare, Tokyo, Japan. The coincidence of moyamoya disease with cerebral vascular malformations including arteriovenous malformation [6, 7], cerebral cavernous malformation [8, 9, 10], and venous malformation [10] has been reported in the literature. A rare association of with dural arteriovenous fistula is also demonstrated [11]. In this chapter, we especially focus on the association of moyamoya disease with further cerebrovascular disease based on our experience.


Intracranial Aneurysm Arteriovenous Malformation Moyamoya Disease Venous Malformation Cavernous Malformation 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


  1. 1.
    Suzuki J, Takaku A (1969) Cerebrovascular ‘moyamoya’ disease. Disease showing abnormal net-like vessels in base of brain. Arch Neurol 20:288–299Google Scholar
  2. 2.
    Adams HP Jr, Kassell NF, Wisoff HS et al (1979) Intracranial saccular aneurysm and moyamoya disease. Stroke 10:174–179PubMedCrossRefGoogle Scholar
  3. 3.
    Konishi Y, Kadowaki C, Hara M et al (1985) Aneurysm associated with moyamoya disease. Neurosurgery 16:484–491PubMedCrossRefGoogle Scholar
  4. 4.
    Kuroda S, Houkin K, Kamiyama H et al (2001) Effects of surgical revascularization on peripheral artery aneurysms in moyamoya disease: report of three cases. Neurosurgery 49:463–467PubMedGoogle Scholar
  5. 5.
    Kodama N, Sato M, Sasaki T (1996) Treatment of ruptured cerebral aneurysm in moyamoya disease. Surg Neurol 46:62–66PubMedCrossRefGoogle Scholar
  6. 6.
    Nakashima T, Nakayama N, Furuichi M et al (1998) Arteriovenous malformation in association with moyamoya disease. Report of two cases. Neurosurg Focus 15:e6Google Scholar
  7. 7.
    Seol HJ, Kim DG, Oh CW (2002) Radiosurgical treatment of a cerebral arteriovenous malformation in a patient with moyamoya disease. Neurosurgery 51:478–481PubMedGoogle Scholar
  8. 8.
    Kerchner GA, Smith W, Lawton MT et al (2006) Co-occurrence of a cavernous malformation and contralateral moyamoya. Neurology 66:1601–1602PubMedCrossRefGoogle Scholar
  9. 9.
    Korematsu K, Yoshioka S, Maruyama T et al (2007) De novo appearance of cerebellar cavernous malformation in a patient with moyamoya disease: case report and review of the literature. Clin Neurol Neurosurg 109:708–712PubMedCrossRefGoogle Scholar
  10. 10.
    Januschek E, Fujimura M, Mugikura S et al (2008) Progressive moyamoya syndrome associated with de novo formation of the ipsilateral venous and contralateral cavernous malformations: case report. Surg Neurol 69:423–427PubMedCrossRefGoogle Scholar
  11. 11.
    Killory BD, Gonzalez LF, Wait SD et al (2008) Simultaneous unilateral moyamoya disease and ipsilateral dural arteriovenous fistula: case report. Neurosurgery 62:1375–1376CrossRefGoogle Scholar
  12. 12.
    Fujimura M, Mugikura S, Kaneta T et al (2009) Incidence and risk factors for symptomatic cerebral hyperperfusion after superficial temporal artery-middle cerebral artery anastomosis in patients with moyamoya disease. Surg Neurol 71:442–447PubMedCrossRefGoogle Scholar
  13. 13.
    Fujimura M, Watanabe M, Shimizu H et al (2007) Expression of matrix metalloproteinase and tissue inhibitor of metalloproteinase in cerebral cavernous malformations: immunihistochemical analysis of MMP-2, -9, and TIMP-2. Acta Neurochir (Wien) 149:179–183CrossRefGoogle Scholar
  14. 14.
    Fujimura M, Watanabe M, Narisawa A et al (2009) Increased expression of serum matrix metalloproteinase-9 in patients with moyamoya disease. Surg Neurol 72:476–480PubMedCrossRefGoogle Scholar

Copyright information

© Springer 2010

Authors and Affiliations

  1. 1.Department of Neurosurgery, Kohnan HospitalTaihaku-kuJapan
  2. 2.Department of NeurosurgeryTohoku University Graduate School of MedicineSendaiJapan

Personalised recommendations